The effect of berberis vulgaris extract on transaminase activities in non-alcoholic fatty liver disease

Hepatitis Monthly

Volumn 15, Issue 2, 2015, Pages

  Kashkooli, Raziye Iloon ^a   Najafi, Seyed Saeed ^a   Sharif, Farkhondeh ^a   Hamedi, Azadeh ^b   Asl, Mohammad Kazem Hoseini ^c   Kalyani, Majid Najafi ^d   Birjandi, Mehdi ^e  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d FASA UNIVERSITY   (Iran)

^e LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alanine transaminase; Aspartate transaminase; Berberis; Non Alcoholic fatty liver disease; Triglycerides

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BERBERIS VULGARIS EXTRACT; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PLANT EXTRACT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BERBERIS VULGARIS; BODY WEIGHT; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; RANDOMIZED CONTROLLED TRIAL;

EID: 84922551050     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.25067     Document Type: Article

References (32)

1. Harte AL, da Silva NF, Creely SJ, McGee KC, Billyard T, Youssef-Elabd EM, et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. J Inflamm (Lond). 2010;7:15.
2. Light N. Epidemiology, clinical features, and diagnosis of nonalcoholic steatohepatitis. 2011;2(19):17–22.
3. Khoshbaten M, Aliasgarzadeh A, Masnadi K, Tarzamani MK, Farhang S, Babaei H, et al. N-acetylcysteine improves liver function in patients with non-alcoholic Fatty liver disease. Hepat Mon. 2010;10(1):12–6.
4. Jamali R, Khonsari M, Merat S, Khoshnia M, Jafari E, Bahram Kalhori A, et al. Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol. 2008;14(18):2867–71.
5. Hajiaghamohammadi AA, Ziaee A, Samimi R. The efficacy of licorice root extract in decreasing transaminase activities in non-alcoholic fatty liver disease: a randomized controlled clinical trial. Phytother Res. 2012;26(9):1381–4.
6. Jamali R. Non-alcoholic fatty liver disease: Diagnosis and evaluation of disease severity. 2013;2(4):43–51.
7. Razavizade M, Jamali R, Arj A, Matini SM, Moraveji A, Taherkhani E. The effect of pioglitazone and metformin on liver function tests, insulin resistance, and liver fat content in nonalcoholic Fatty liver disease: a randomized double blinded clinical trial. Hepat Mon. 2013;13(5).
8. Kirovski G, Schacherer D, Wobser H, Huber H, Niessen C, Beer C, et al. Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics. Int J Clin Exp Med. 2010;3(3):202–10
9. Kotronen A, Yki-Jarvinen H, Mannisto S, Saarikoski L, Korpi-Hyovalti E, Oksa H, et al. Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D survey. BMC Public Health. 2010;10:237
10. Savadkoohi F, Hosseini-Tabatabaei MT, Shahabi Nezhad S. The frequency of fatty liver in sonography of patients withou liver diseases background and its correlation with blood cholesterol and triglycerid. Iranian J Tabibe Shargh. 2003;5(3):177–83
11. Eslami L, Merat S, Nasseri-Moghaddam S. Treatment of non-alcoholic fatty liver disease (nafld): A systematic review. MEJDD. 2009;1(2):89–99
12. Jamali R. Non-alcoholic fatty liver disease: Diagnosis and evaluation of disease severity. Thrita J Med Sci. 2013;2(2):43–51
13. Stickel F, Schuppan D. Herbal medicine in the treatment of liver diseases. Dig Liver Dis. 2007;39(4):293–304
14. Chang X, Yan H, Fei J, Jiang M, Zhu H, Lu D, et al. Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats. J Lipid Res. 2010;51(9):2504–15
15. Murugesh K, Yeligar VC, Maiti CB, Maity TK. Hepato protective and antioxidant role of Berberis tinctoria Lesch leaves on paracetamol induced hepatic damage in rats. 2005;4(1):64–9
16. Das S, Das MK, Mazumder PM, Das S, Basu SP. Cytotoxic activity of methanolic extract of Berberis aristata DC on colon cancer. Global J Pharmacol. 2009;3(3):137–40
17. Murugesh KS, Yeligar VC, Maiti CB, Maity TK. Hepato protective and antioxidant role of Berberis tinctoria Lesch leaves on paracetamol induced hepatic damage in rats. 2005(4):64–9
18. Hanachi P, Golkho SH. Using HPLC to determination the composition and antioxidant activity of Berberis vulgaris. Europ J Sci Res. 2009;29(1):47–54
19. Hanachi P, Kua SH, Asmah R, Motalleb G, Fauziah O. Cytotoxic Effect of Berberis vulgaris Fruit Extract on the Proliferation of Human Liver Cancer Cell Line (HepG2) and its Antioxidant Properties. Int J Canc Res. 2006;2(1):1–9
20. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci. 2010;55(3):560–78
21. Tavangar SM, Khadem Sameni F, Derakhshan MH, Merat SH, Mehrnami A, Malekzadeh R., Correlation Of The Serum Levels Of The Alt And Ast With The Degree Of Inflammation And Fibrosis In The Liver Of Patients With Non-Alcoholic Steatohepatitis: Validation Of The Revisions Applied On The Brunt Scoring System. HAKIM. 2006;8(4):1
22. Federico A, Trappoliere M, Loguercio C. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives. Dig Liver Dis. 2006;38(11):789–801
23. Motalleb G, Hanachi P, Kua SH, Fauziah O, Asmah R. Evaluation of Phenolic Content and Total Antioxidant Activity in Berberis vulgaris Fruit Extract. J Biol Sci. 2005;5(5):648–53
24. Wei J, Wu J, Jiag J. Clinical study on improvement of typeⅡdiabetes mellitus complicated with fatty liver treated by berberine. Chinese J Integ Tradition West Med Liver Dis. 2004;6:334–6
25. Yang QH, Hu SP, Zhang YP, Xie WN, Li N, Ji GY, et al. Effect of berberine on expressions of uncoupling protein-2 mRNA and protein in hepatic tissue of non-alcoholic fatty liver disease in rats. Chin J Integr Med. 2011;17(3):205–11
26. Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008;93(7):2559–65
27. Taheri S, Zarei A, Changizi Ashtiyani S, Rezaei A, Zaheiri S. Evaluation of the effects of hydroalcoholic extract of Berberis vulgaris root on the activity of liver enzymes in male hypercholesterolemic rats. Avicenna J Phytomed. 2012;2(3):153–61
28. Motalleb G, Hanachi P, Fauziah O, Asmah R. Effect of Berberis vulgaris fruit extract on alpha-fetoprotein gene expression and chemical carcinogen metabolizing enzymes activities in hepatocarcinogenesis rats. Iran J Cancer Prev. 2012;1(1):33–42
29. Eidi A, Zarin-Ghalam J. Hepatoprotective effect of Berberis vulgaris L. extract on CCl4-induced toxicity in rats. 2011;16(3):169–73
30. Ebrahimi-Mamaghani M, Arefhosseini SR, Golzarand M, Aliasgarzadeh A, Vahed-Jabbary M. Long-term effects of processed Berberis vulgaris on some metabolic syndrome components. Iran J Endocrinol Metabol. 2009;11(1):41–7
31. Farhadi A, Gavadifar K. Effects of berberise vulgaris fruit extract on blood cholesterol and triglyceride in hyperlipidemic patients . J Semnan Univ Med Sci. 2008;9(3):211–6
32. Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008;57(5):712–7.